Shining on Major News: Sangamo Biosciences Inc. (NASDAQ:SGMO), Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), DaVita HealthCare Partners Inc. (NYSE:DVA),

On 24 February, Sangamo Biosciences Inc. (NASDAQ:SGMO) announced the presentation of immunological data from the Company’s clinical trials of SB-728-T, a ZFP Therapeutic®designed to provide functional control of HIV. Analysis of data from Sangamo’s most recent SB-728-1101 study suggests key, potentially interrelated mechanisms for viral load (VL) control in treated subjects during a treatment interruption (TI) from their antiretroviral therapy (ART).

Sangamo Biosciences Inc. (NASDAQ:SGMO) belongs to Healthcare sector. Its weekly performance is -7.26%. On last trading day company shares ended up at $5.24. Sangamo Biosciences Inc. (NASDAQ:SGMO) distance from 50-day simple moving average (SMA50) is -5.69%.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) is set to release its Q415 earnings data on Wednesday, March 2nd. Analysts expect Catabasis Pharmaceuticals to post earnings of ($0.69) per share for the quarter.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) shares decreased -5.19% in last trading session and ended the day at $4.20. CATB return on assets is -58.30%. Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) quarterly performance is -48.78%.

On 18 February, DaVita HealthCare Partners Inc. (NYSE:DVA) announced the company was recognized among Trainingmagazine’s Top 125 for its whole-person learning approach to training and development programs. The company has appeared on the list for 12 years in a row.

On 29 February, DaVita HealthCare Partners Inc. (NYSE:DVA) shares decreased -0.74% and was closed at $65.97. DVA EPS growth in last 5 year was -8.60%. DaVita HealthCare Partners Inc. (NYSE:DVA) year to date (YTD) performance is -5.37%.

Acuity Brands, Inc. (NYSE:AYI)‘s stock had its “buy” rating restated by analysts at Piper Jaffray in a note issued to investors on Tuesday, AnalystRatings.NET reports.

Acuity Brands, Inc. (NYSE:AYI) ended the last trading day at $209.43. Company weekly volatility is calculated as 2.31% and price to cash ratio as 16.37. Acuity Brands, Inc. (NYSE:AYI) showed a weekly performance of 6.03%.

Virtus Investment Partners, Inc. (NASDAQ:VRTS) announced that its Board of Directors has declared a quarterly cash dividend of $0.45per common share for the first quarter of 2016.The dividend will be paid on May 13, 2016 to shareholders of record at the close of business on April 29, 2016. Future declarations of quarterly dividends will be subject to the approval of the Board of Directors.

Virtus Investment Partners, Inc. (NASDAQ:VRTS) shares decreased -1.83% in last trading session and ended the day at $91.81. VRTS return on assets is 4.50%. Virtus Investment Partners, Inc. (NASDAQ:VRTS) quarterly performance is -31.62%.

Leave a Reply

Your email address will not be published. Required fields are marked *